AVAI — AVAI BIO, INC.
—
OTC ·
Information Technology ·
IT Services ·
CIK 1740797 ·
Last close
$0.12
Market Cap
$18.47M
52W High
$0.80
52W Low
$0.10
ADV30
101,777
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -419,783 | -552,041 | 791,750 | 83,586 | 4,014,316 |
| Mar 2026 | 0 | — | 14,141 | -255,177 | 572,696 | 23,145 | 3,387,851 |
| Dec 2025 | 0 | — | -553,727 | -553,727 | 172,912 | 50,402 | 2,967,398 |
| Sep 2025 | 0 | — | -453,016 | -453,016 | 231,372 | 91,995 | 2,532,131 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,146,517
Investing CF
$0
Financing CF
$1,193,849
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,612,842
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,030,260
Pretax Income TTM
$-1,030,260
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -1,480,191 | -1,749,509 | 572,696 | 3,387,851 | -2,815,155 | -1,009,844 |
| Mar 2025 | 0 | -1,532,792 | -1,142,115 | 224,745 | 1,788,617 | -1,563,872 | -1,160,610 |
| Mar 2024 | 0 | -2,128,475 | -2,128,475 | 322,014 | 1,788,580 | -1,466,566 | -1,322,318 |
| Mar 2023 | 276,324 | -348,933 | -348,933 | 241,460 | 874,719 | -633,259 | -54,457 |
| Mar 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
$-1,032,260
OpCashFlow TTM
—
Assets (Latest)
$172,912
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MNDO | MIND CTI LTD | $18.48M | $0.92 | — |
| BIRD | Smartbird, Inc. | $18.07M | $2.88 | — |
| AIJTY | Jianpu Technology Inc. | $19.23M | $0.96 | — |
| SST | System1, Inc. | $19.77M | $2.27 | — |
| JF | J & Friends Holdings Ltd | $16.29M | $0.95 | — |
News headlines (Yahoo Finance, 1h cache)
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
2026-10-07 12:45 · Yahoo
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
2026-09-30 12:45 · Yahoo
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
2026-09-24 12:45 · Yahoo
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
2026-07-21 13:00 · Yahoo
Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference
2026-04-07 12:00 · Yahoo
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
2026-08-12 12:30 · Yahoo
Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy
2026-05-20 12:45 · Yahoo
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
2026-09-15 12:45 · Yahoo
Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy
2026-07-21 12:00 · Yahoo
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
2026-03-03 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.